EARN25

2 Vaccine Stocks Gapping Lower on RFK Jr. Nomination

Options traders are blasting PFE and MRNA

Digital Content Manager
Nov 15, 2024 at 10:26 AM
facebook X logo linkedin


President Elect Donald Trump called on Robert F. Kennedy Jr. to lead the Department of Health and Human Services. Kennedy is the chairman of anti-vaccine nonprofit Children's Health Defense, and has positioned himself against immunization on several occasions. In response to the nomination, Pfizer Inc (NYSE:PFE) and Moderna Inc (NASDAQ:MRNA) shares are gapping lower.

PFE was last seen down 4.7% to trade at $24.79 -- its lowest level since April --  and is now on track for its fifth loss in the last six sessions. Shares currently carry a 12.6% year-to-date deficit and have been trading firmly below their descending 20-day moving average since late October.

MRNA is down 5% to trade at a four-year low $37.80 at last check, pacing for its third-straight daily loss and worst week since August. The 20-day moving average has been pressuring the shares lower since June, contributing to a steep 70% six-month deficit.

Drilling down to PFE's options activity, 55,000 calls and 51,000 puts have exchanged hands so far today -- four times the intraday average volume -- with new positions being opened at the most active November 25 put. MRNA has seen 9,515 calls and 13,000 puts traded so far, which is double the volume typically seen at this point. The most popular contract for the latter is the weekly 11/22 40-strike call, where new positions are also being opened.

Getting Started With Options:
OPTIONS BASICS

Are you ready to start learning about options, and how to use them for faster profits? Our FREE GUIDE breaks down basic options trading concepts and vocabulary, how options derive their value, advantages and disadvantages, trading mechanics, and more!


 

You Don’t Need 25 Alerts -- You Need ONE You Can Trust!

That’s the idea behind Trade of the Week, Schaeffer’s newest trade alert.

Every Monday morning before the opening bell, you’ll receive a single, expertly researched trade recommendation -- built from the same proprietary research we’ve been using for over four decades.

It’s not just a signal.

It’s a plan designed for traders who are tired of jumping from alert to alert without ever finding their edge.

No juggling alerts. No switching directions mid-week. Just one clear, expertly researched trade idea -- delivered before the market even opens.

👉 JOIN RIGHT NOW FOR JUST $1 TO GET THE NEXT TRADE!